Nodular Lymphocyte-Predominant Hodgkin Lymphoma Dennis A. Eichenauer University Hospital Cologne, Cologne, Germany and German Hodgkin Study Group (GHSG), Cologne, Germany Multiple Choice Questions 1. Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) and classical…
Autologous Hematopoietic Cell Transplantation in Multiple Myeloma Jean-Luc Harousseau1 and Mohamad Mohty2 1French National Cancer Institute, Nantes, France 2University Pierre & Marie Curie, Paris, France 1. Is high-dose therapy plus autologous…
Light-Chain Amyloidosis David C. Seldin Boston University, Boston, MA, USA Case study 57.1 An 80-year-old man is referred to you for evaluation and treatment. The patient had been noted by…
Treatment of Multiple Myeloma Cindy Varga, Claudia Paba Prada, Kenneth Anderson, and Paul Richardson Dana-Farber Cancer Institute, Boston, MA, USA Prognostic Markers Introduction Multiple myeloma is a heterogeneous disease with…
Primary Myelofibrosis Ayalew Tefferi Mayo Clinic, Rochester, MN, USA Introduction Primary myelofibrosis (PMF) is listed under the World Health Organization (WHO) classification category of myeloproliferative neoplasms (MPNs). The operational subcategory…
Risk Stratification and Response Assessment in Multiple Myeloma and Waldenström’s Macroglobulinemia Silvia Gentili1 and Sagar Lonial2 1Azienda Ospedaliero-Universitaria, Ospedali Riuniti di Ancona, Ancona, Italy 2The Winship Cancer Institute of Emory…
Hematopoietic Cell Transplantation in Diffuse Large B-cell Lymphoma Syed A. Abutalib and Istvan Redei Cancer Treatment Centers of America, Zion, IL, USA Case study 52.1 You are requested to see…
Hematopoietic Cell Transplantation in T-Cell Non-Hodgkin’s Lymphomas Lori S. Muffly and Sonali M. Smith The University of Chicago, Chicago, IL, USA Introduction Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group…
HIV-Associated Lymphoma Kieron Dunleavy National Cancer Institute, Bethesda, MD, USA 1. What are the most important etiological factors for the development of HIV-associated lymphoma? The pathogenesis of HIV-associated lymphoma is complex…
Gray Zone Lymphoma Caron A. Jacobson1 and Ann S. LaCasce2 1Dana-Farber Cancer Institute, Boston, MA, USA 2Dana-Farber/Partners CancerCare, Boston, MA, USA Case study 45.1 A 62-year-old woman presents to the…
